ArticleJTCVS open2026
Predictors of long-term survival after pulmonary endarterectomy.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients undergoing pulmonary thromboendarterectomy (PTE) have successful early to mid-term outcomes; however, they may not have consistent long-term follow-up. We aimed to examine the long-term survival and predictors of outcomes after PTE. Methods: Between 2008 and 2022, 308 patients with chronic thromboembolic pulmonary hypertension (CTEPH) underwent PTE at a tertiary institution. Baseline, operative, and postoperative variables were obtained from the institutional database. Survival follow-up was completed and analyzed with Kaplan-Meier estimates. The median duration of follow-up was 4.5 years, and multivariable analysis was performed for long-term survival. Results: Among the 308 patients, 50% had moderate or more right ventricular (RV) dysfunction, and preoperative mean pulmonary artery pressure (mPAP) was 43 mm Hg (15th-18th percentile, 31-55 mm Hg). The median circulatory arrest time during PTE was 35 minutes (15th-18th percentile, 23-49.7 minutes). Fifteen percent of the patients underwent concomitant tricuspid valve repair, while 5.5% had a reoperation. Operative mortality was 2.3%, and 7% of patients required extracorporeal membrane oxygenation after PTE. Postoperative mPAP was reduced to 26 mm Hg (15th-18th percentile, 19-35.5 mm Hg). Survival rates after PTE were 97% at 1 year, 90.4% at 5 years, and 79% at 8 years. The study cohort was stratified into 4 groups by preoperative RV dysfunction grade (normal, mild, moderate, and severe), and there was no significant difference in survival among the groups up to 5 years ( Conclusions: The degree of preoperative RV dysfunction did not influence long-term survival after PTE. However, postoperative mPAP was associated with worse survival, suggesting the need for close follow-up of these patients to monitor compliance, pulmonary vascular or RV remodeling, and progression of CTEPH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.